Company Website

Contact Information:

Sandra Kristjanson
skristjanson@epizyme.com
630-240-6130

Janet Huss
jhuss@epizyme.com
763-639-0742

Virtual Exhibit Hall Home

Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.

Additional Information

Please join Epizyme representatives in our virtual meeting room before the conference and at breaks.

Tazverik in Follicular Lymphoma

Package Insert

Epizyme Now Patient Support Program